Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
CERN Stock Summary
In the News
Oracle Reports Booming Growth, Signaling That its $28 Billion Purchase of Cerner Is Paying Off
Cerner contributed $1.5 billion dollars in revenue.
Oracle's Cerner Purchase Shows Aggressive Strategy in Volatile Times
Oracle ( ORCL , Financial) is one of the most profitable software companies in the world. It has a diversified business model, insulating against market downturns.
2 software stocks that could weather a recession hailstorm
With the possibility of a recession on the cards, investors should look to determine which firms have a reasonable chance.
Oracle quietly closes $28B deal to buy electronic health records company Cerner
At the end of last year, just before Christmas, Oracle made a big move when it announced it was acquiring electronic health records company Cerner for $28 billion, thrusting it quickly into the top enterprise deal for 2021, just under the wire. Today, the company announced it has closed the deal, effective tomorrow.
Billionaire Paul Tudor Jones Is Betting Big on These 3 Stocks
Paul Tudor Jones II first gained notoriety by shorting the Black Monday Crash of 1987. Now, he's betting big on CERN, PLAN, and SPY puts.
Why Is Cerner (CERN) Up 0.3% Since Last Earnings Report?
Cerner (CERN) reported earnings 30 days ago. What's next for the stock?
Oracle gains EU green light for $28.3 billion Cerner deal
U.S. business software maker Oracle Corp has secured unconditional EU antitrust clearance for its $28.3 billion acquisition of U.S. healthcare IT company Cerner Corp, the EU competition enforcer said on Thursday.
Oracle's $28.3B Cerner deal near after regulatory hurdles cleared
Oracle expects to complete its $95 per share tender offer for Cerner on June 6 paving the way for the company's largest acquisition ever.
Here's Why Investors Should Retain Cerner (CERN) Stock Now
Cerner (CERN) continues to gain traction from its robust strategic deals. However, stiff competition remains a woe.
Exclusive-EU set to clear without conditions $28.3 billion Oracle, Cerner deal - sources
EU antitrust regulators are set to approve without conditions U.S. business software maker Oracle Corp's $28.3 billion acquisition of U.S. healthcare IT company Cerner Corp, people familiar with the matter said on Tuesday.
CERN Financial details
CERN Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2017-12-30 | 2018-12-29 | 2019-12-28 | 2020-12-31 | 2021-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 15.52 | 16.09 | 17.72 | 17.81 | 18.8 | |
Net income per share | 2.62 | 1.89 | 1.65 | 2.52 | 1.81 | |
Operating cash flow per share | 3.95 | 4.36 | 4.09 | 4.65 | 5.78 | |
Free cash flow per share | 1.94 | 2.09 | 1.66 | 2.65 | 3.73 | |
Cash per share | 2.43 | 2.32 | 1.69 | 3.42 | 2.75 | |
Book value per share | 14.44 | 14.77 | 13.44 | 14.5 | 12 | |
Tangible book value per share | 7.94 | 8.34 | 6.63 | 7.21 | 3.56 | |
Share holders equity per share | 14.44 | 14.77 | 13.44 | 14.5 | 12 | |
Interest debt per share | 1.61 | 1.35 | 3.28 | 4.42 | 6.13 | |
Market cap | 22.33B | 17.35B | 23.54B | 24.26B | 28.48B | |
Enterprise value | 22.49B | 17.42B | 24.14B | 24.98B | 29.73B | |
P/E ratio | 25.76 | 27.54 | 44.46 | 31.1 | 51.26 | |
Price to sales ratio | 4.34 | 3.23 | 4.14 | 4.41 | 4.94 | |
POCF ratio | 17.08 | 11.93 | 17.93 | 16.89 | 16.08 | |
PFCF ratio | 34.79 | 24.91 | 44.24 | 29.62 | 24.89 | |
P/B Ratio | 4.67 | 3.52 | 5.45 | 5.41 | 7.74 | |
PTB ratio | 4.67 | 3.52 | 5.45 | 5.41 | 7.74 | |
EV to sales | 4.37 | 3.25 | 4.24 | 4.54 | 5.16 | |
Enterprise value over EBITDA | 14.45 | 12 | 17.79 | 14.54 | 20.34 | |
EV to operating cash flow | 17.2 | 11.98 | 18.38 | 17.39 | 16.78 | |
EV to free cash flow | 35.04 | 25.01 | 45.36 | 30.49 | 25.98 | |
Earnings yield | 0.04 | 0.04 | 0.02 | 0.03 | 0.02 | |
Free cash flow yield | 0.03 | 0.04 | 0.02 | 0.03 | 0.04 | |
Debt to equity | 0.11 | 0.09 | 0.24 | 0.3 | 0.5 | |
Debt to assets | 0.08 | 0.07 | 0.15 | 0.18 | 0.25 | |
Net debt to EBITDA | 0.1 | 0.05 | 0.44 | 0.42 | 0.85 | |
Current ratio | 3.01 | 2.41 | 2.04 | 2.27 | 1.51 | |
Interest coverage | 119.88 | 97.01 | 41.51 | 31.45 | 17.09 | |
Income quality | 1.51 | 2.31 | 2.48 | 1.84 | 3.19 | |
Dividend Yield | 0 | 0 | 0 | 0.01 | 0.01 | |
Payout ratio | 0 | 0 | 0.21 | 0.28 | 0.48 | |
Sales general and administrative to revenue | 0.51 | 0.54 | 0.56 | 0.09 | 0.09 | |
Research and developement to revenue | 0.08 | 0.09 | 0.09 | 0.14 | 0.15 | |
Intangibles to total assets | 0.33 | 0.32 | 0.32 | 0.3 | 0.35 | |
Capex to operating cash flow | -0.51 | -0.52 | -0.59 | -0.43 | -0.35 | |
Capex to revenue | -0.13 | -0.14 | -0.14 | -0.11 | -0.11 | |
Capex to depreciation | -1.15 | -1.18 | -1.14 | -0.89 | -0.87 | |
Stock based compensation to revenue | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | |
Graham number | 29.16 | 25.06 | 22.32 | 28.69 | 22.12 | |
ROIC | 0.16 | 0.11 | 0.09 | 0.12 | 0.11 | |
Return on tangible assets | 0.2 | 0.14 | 0.11 | 0.15 | 0.11 | |
Graham Net | -0.27 | -0.31 | -3.64 | -3.53 | -6.61 | |
Working capital | 1.59B | 1.36B | 1.07B | 1.48B | 823.2M | |
Tangible asset value | 2.63B | 2.78B | 2.13B | 2.23B | 1.09B | |
Net current asset value | 696.26M | 538.56M | -480.67M | -387.54M | -1.3B | |
Invested capital | 0.11 | 0.09 | 0.24 | 0.3 | 0.5 | |
Average receivables | 993.86M | 1.11B | 1.16B | 1.15B | 1.17B | |
Average payables | 228.57M | 256.27M | 283.49M | 254.6M | 282.67M | |
Average inventory | 15.24M | 20.39M | 24.11M | 23.1M | 25.59M | |
Days sales outstanding | 74.02 | 80.5 | 73.07 | 77.48 | 73.53 | |
Days payables outstanding | 93.59 | 114.3 | 93.19 | 92.24 | 120.18 | |
Days of inventory on hand | 6.73 | 9.75 | 7.9 | 9.01 | 10.27 | |
Receivables turnover | 4.93 | 4.53 | 5 | 4.71 | 4.96 | |
Payables turnover | 3.9 | 3.19 | 3.92 | 3.96 | 3.04 | |
Inventory turnover | 54.23 | 37.45 | 46.2 | 40.52 | 35.55 | |
ROE | 0.18 | 0.13 | 0.12 | 0.17 | 0.15 | |
Capex per share | -2.01 | -2.27 | -2.43 | -2 | -2.05 |
Quarterly Fundamentals Overview
Last date of statement is 2022-03-31 for Q1
Metric | History | 2021-03-31 | 2021-06-30 | 2021-09-30 | 2021-12-31 | 2022-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 4.55 | 4.84 | 4.96 | 4.95 | 4.82 | |
Net income per share | 0.57 | 0.11 | 0.59 | 0.6 | 0.7 | |
Operating cash flow per share | 1.48 | 1.23 | 1.47 | 1.76 | 1.27 | |
Free cash flow per share | 0.93 | 0.51 | 1.03 | 1.37 | 0.92 | |
Cash per share | 4.84 | 2.94 | 2.64 | 2.87 | 2.97 | |
Book value per share | 14.15 | 13.39 | 12.96 | 12.54 | 13.19 | |
Tangible book value per share | 6.75 | 4.66 | 4.15 | 3.72 | 4.52 | |
Share holders equity per share | 14.15 | 13.39 | 12.96 | 12.54 | 13.19 | |
Interest debt per share | 6.03 | 6.11 | 6.2 | 6.26 | 5.44 | |
Market cap | 21.9B | 23.51B | 20.89B | 27.25B | 27.73B | |
Enterprise value | 22.74B | 25.1B | 22.26B | 28.49B | 28.63B | |
P/E ratio | 31.79 | 179.67 | 29.71 | 38.96 | 33.63 | |
Price to sales ratio | 15.78 | 16.14 | 14.23 | 18.76 | 19.39 | |
POCF ratio | 48.63 | 63.68 | 48.04 | 52.67 | 73.92 | |
PFCF ratio | 77.4 | 152.47 | 68.59 | 67.66 | 102.06 | |
P/B Ratio | 5.08 | 5.84 | 5.44 | 7.4 | 7.09 | |
PTB ratio | 5.08 | 5.84 | 5.44 | 7.4 | 7.09 | |
EV to sales | 16.39 | 17.23 | 15.17 | 19.62 | 20.02 | |
Enterprise value over EBITDA | 57.64 | 110.49 | 55.51 | 72.04 | 67.01 | |
EV to operating cash flow | 50.49 | 67.98 | 51.2 | 55.08 | 76.33 | |
EV to free cash flow | 80.37 | 162.78 | 73.11 | 70.75 | 105.38 | |
Earnings yield | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Debt to equity | 0.43 | 0.46 | 0.48 | 0.5 | 0.41 | |
Debt to assets | 0.23 | 0.24 | 0.24 | 0.25 | 0.22 | |
Net debt to EBITDA | 2.12 | 7 | 3.43 | 3.15 | 2.11 | |
Current ratio | 2.09 | 1.65 | 1.57 | 1.51 | 1.79 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 2.61 | 11.29 | 2.47 | 2.96 | 1.82 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.39 | 2.07 | 0.38 | 0.37 | 0.38 | |
Sales general and administrative to revenue | 0.08 | 0.11 | 0.08 | 0.09 | 0.08 | |
Research and developement to revenue | 0.14 | 0.17 | 0.14 | 0.14 | 0.14 | |
Intangibles to total assets | 0.29 | 0.34 | 0.35 | 0.35 | 0.35 | |
Capex to operating cash flow | -0.37 | -0.58 | -0.3 | -0.22 | -0.28 | |
Capex to revenue | -0.12 | -0.15 | -0.09 | -0.08 | -0.07 | |
Capex to depreciation | -0.96 | -1.2 | -0.72 | -0.63 | -0.59 | |
Stock based compensation to revenue | 0.03 | 0.04 | 0.04 | 0.03 | 0.02 | |
Graham number | 13.42 | 5.72 | 13.16 | 12.97 | 14.37 | |
ROIC | 0.03 | 0.01 | 0.03 | 0.03 | 0.04 | |
Return on tangible assets | 0.03 | 0.01 | 0.04 | 0.04 | 0.04 | |
Graham Net | -4.02 | -6.22 | -6.73 | -6.91 | -5.69 | |
Working capital | 1.59B | 997.91M | 888.83M | 823.2M | 1.09B | |
Tangible asset value | 2.06B | 1.4B | 1.23B | 1.09B | 1.34B | |
Net current asset value | -540.79M | -1.15B | -1.26B | -1.3B | -997.86M | |
Invested capital | 0.43 | 0.46 | 0.48 | 0.5 | 0.41 | |
Average receivables | 1.17B | 1.21B | 1.23B | 1.19B | 1.17B | |
Average payables | 257.51M | 306.11M | 322.08M | 320.39M | 344.57M | |
Average inventory | 26.73M | 25.31M | 22.78M | 26.77M | 27.93M | |
Days sales outstanding | 76.21 | 76.44 | 74.79 | 71.97 | 74.15 | |
Days payables outstanding | 108.96 | 114.67 | 111.53 | 115 | 132.71 | |
Days of inventory on hand | 11.88 | 6.95 | 9.1 | 9.83 | 10.23 | |
Receivables turnover | 1.18 | 1.18 | 1.2 | 1.25 | 1.21 | |
Payables turnover | 0.83 | 0.78 | 0.81 | 0.78 | 0.68 | |
Inventory turnover | 7.58 | 12.96 | 9.89 | 9.16 | 8.8 | |
ROE | 0.04 | 0.01 | 0.05 | 0.05 | 0.05 | |
Capex per share | -0.55 | -0.71 | -0.44 | -0.39 | -0.35 |
CERN Frequently Asked Questions
What is Cerner Corporation stock symbol ?
Cerner Corporation is a US stock , located in Kansas city of Missouri and trading under the symbol CERN
Is Cerner Corporation buy or a sell ?
6 stock analysts have 6 predictions with a medium analyst target price of $89.83. The lowest prediction is $85 and the highest is $95
What is CERN stock prediction ?
What is Cerner Corporation stock quote today ?
Cerner Corporation stock price is $- today.
Is Cerner Corporation stock public?
Yes, Cerner Corporation is a publicly traded company.